JP2011168603A5 - - Google Patents

Download PDF

Info

Publication number
JP2011168603A5
JP2011168603A5 JP2011087496A JP2011087496A JP2011168603A5 JP 2011168603 A5 JP2011168603 A5 JP 2011168603A5 JP 2011087496 A JP2011087496 A JP 2011087496A JP 2011087496 A JP2011087496 A JP 2011087496A JP 2011168603 A5 JP2011168603 A5 JP 2011168603A5
Authority
JP
Japan
Prior art keywords
phe
lys
arg
composition
peptide represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011087496A
Other languages
English (en)
Other versions
JP5650040B2 (ja
JP2011168603A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011168603A publication Critical patent/JP2011168603A/ja
Publication of JP2011168603A5 publication Critical patent/JP2011168603A5/ja
Application granted granted Critical
Publication of JP5650040B2 publication Critical patent/JP5650040B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Claims (3)

  1. Phe-D-Arg-Phe-Lys-NH 2 なる配列によって表されるペプチド
  2. Phe-D-Arg-Phe-Lys-NH 2 なる配列によって表されるペプチドを含む組成物
  3. 製薬的に許容される担体を含む請求項2記載の組成物
JP2011087496A 2003-05-01 2011-04-11 細胞に分子を送達する方法及び担体複合体 Expired - Lifetime JP5650040B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46751603P 2003-05-01 2003-05-01
US60/467,516 2003-05-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006532552A Division JP4879020B2 (ja) 2003-05-01 2004-05-03 細胞に分子を送達する方法及び担体複合体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014178031A Division JP5995930B2 (ja) 2003-05-01 2014-09-02 細胞に分子を送達する方法及び担体複合体

Publications (3)

Publication Number Publication Date
JP2011168603A JP2011168603A (ja) 2011-09-01
JP2011168603A5 true JP2011168603A5 (ja) 2012-07-12
JP5650040B2 JP5650040B2 (ja) 2015-01-07

Family

ID=33551404

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2006532552A Expired - Lifetime JP4879020B2 (ja) 2003-05-01 2004-05-03 細胞に分子を送達する方法及び担体複合体
JP2011087496A Expired - Lifetime JP5650040B2 (ja) 2003-05-01 2011-04-11 細胞に分子を送達する方法及び担体複合体
JP2014178031A Expired - Lifetime JP5995930B2 (ja) 2003-05-01 2014-09-02 細胞に分子を送達する方法及び担体複合体
JP2016050272A Expired - Lifetime JP6395749B2 (ja) 2003-05-01 2016-03-14 細胞に分子を送達する方法及び担体複合体
JP2018133252A Expired - Lifetime JP6698756B2 (ja) 2003-05-01 2018-07-13 細胞に分子を送達する方法及び担体複合体
JP2020032792A Pending JP2020105184A (ja) 2003-05-01 2020-02-28 細胞に分子を送達する方法及び担体複合体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006532552A Expired - Lifetime JP4879020B2 (ja) 2003-05-01 2004-05-03 細胞に分子を送達する方法及び担体複合体

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2014178031A Expired - Lifetime JP5995930B2 (ja) 2003-05-01 2014-09-02 細胞に分子を送達する方法及び担体複合体
JP2016050272A Expired - Lifetime JP6395749B2 (ja) 2003-05-01 2016-03-14 細胞に分子を送達する方法及び担体複合体
JP2018133252A Expired - Lifetime JP6698756B2 (ja) 2003-05-01 2018-07-13 細胞に分子を送達する方法及び担体複合体
JP2020032792A Pending JP2020105184A (ja) 2003-05-01 2020-02-28 細胞に分子を送達する方法及び担体複合体

Country Status (18)

Country Link
US (6) US7704954B2 (ja)
EP (7) EP3381515B1 (ja)
JP (6) JP4879020B2 (ja)
KR (1) KR101161823B1 (ja)
CN (2) CN100506841C (ja)
AU (1) AU2004252419B2 (ja)
BR (1) BRPI0409911A (ja)
CA (1) CA2524258C (ja)
DK (4) DK1625149T3 (ja)
ES (3) ES2520815T3 (ja)
HK (6) HK1089450A1 (ja)
MX (1) MXPA05011773A (ja)
NZ (1) NZ543410A (ja)
PL (2) PL2604286T3 (ja)
PT (2) PT2604286E (ja)
SI (1) SI2604285T1 (ja)
WO (1) WO2005001023A2 (ja)
ZA (1) ZA200509229B (ja)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030062788A (ko) * 2002-01-19 2003-07-28 포휴먼텍(주) 생체분자 전달 펩타이드 mph1-btm 및 이것을포함하는 생명공학제품
DK2656854T3 (en) 2003-02-04 2015-07-06 Cornell Res Foundation Inc Applications of an aromatic-cationic peptide
DK1625149T3 (en) * 2003-05-01 2016-05-30 Cornell Res Foundation Inc METHOD AND carrying complexes for delivery of molecules to cells
CA2971928C (en) * 2004-01-23 2019-01-08 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
US7534819B2 (en) * 2005-06-10 2009-05-19 University Of Washington Compositions and methods for intracellular delivery of biotinylated cargo
CA2947343C (en) 2005-09-16 2019-04-30 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
JP2010509181A (ja) * 2005-11-04 2010-03-25 フォーヒューマンテック・カンパニー・リミテッド 融合ポリペプチドを細胞へ輸送する方法
CN101490080A (zh) * 2006-07-24 2009-07-22 为人技术株式会社 用于缓解和治疗缺血性病症的药物组合物及其输送方法
WO2008047243A2 (en) * 2006-08-29 2008-04-24 Forhumantech. Co., Ltd. Pharmaceutical composition for suppression of apoptosis and method for delivering the same
US8889632B2 (en) 2007-01-31 2014-11-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
KR101623985B1 (ko) 2007-03-28 2016-05-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
US7981446B2 (en) * 2007-11-26 2011-07-19 Forhumantech. Co., Ltd. Pharmaceutical compositions and methods for delivering nucleic acids into cells
CN101939019B (zh) 2008-02-07 2014-07-16 康奈尔大学 用于预防或治疗胰岛素抵抗性的方法
EP2262520B1 (en) 2008-02-26 2017-05-03 Cornell University Compositions for prevention and treatment of renal injury
WO2010034034A1 (en) * 2008-09-22 2010-03-25 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
WO2010060112A1 (en) 2008-11-24 2010-05-27 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with improved properties
DE102008061044A1 (de) * 2008-12-11 2010-06-17 Henkel Ag & Co. Kgaa Zusammensetzung mit antioxidativ wirksamen Peptiden
CN103933542A (zh) 2009-03-20 2014-07-23 通用医疗公司以马萨诸塞州通用医疗公司名义经营 预防和治疗烧伤损伤和继发性并发症的方法
US20110039766A1 (en) * 2009-08-12 2011-02-17 Szeto Hazel H Methods for preventing or treating metabolic syndrome
EP3338788A1 (en) 2009-08-24 2018-06-27 Stealth Peptides International, Inc. Methods and copositions for preventing or treating opthalmic conditions
JP2013506696A (ja) * 2009-10-05 2013-02-28 コーネル ユニヴァーシティー 心不全の予防又は処置の方法
US20110245183A1 (en) * 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
US20110245182A1 (en) * 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
EP2566880A4 (en) * 2010-05-03 2014-10-08 Stealth Peptides Int Inc AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
CN102010461B (zh) * 2010-10-11 2014-02-12 华南理工大学 一种alpha螺旋状阳离子多肽分子及其制法和应用
GB201018125D0 (en) * 2010-10-26 2010-12-08 Marealis As Peptide
CN103796665B (zh) * 2011-03-24 2018-10-30 康奈尔大学 芳香族阳离子肽及其用途
AU2012271691A1 (en) * 2011-06-14 2014-01-16 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
JP6025311B2 (ja) 2011-08-01 2016-11-16 キヤノン株式会社 眼科診断支援装置および方法
WO2013049697A1 (en) 2011-09-29 2013-04-04 Mayo Foundation For Medical Education And Research Aromatic-cationic peptides and methods for using same
EP2768516A4 (en) * 2011-10-17 2015-08-19 Univ Cornell AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
JP6342808B2 (ja) 2011-10-18 2018-06-13 エイルロン セラピューティクス,インコーポレイテッド ペプチドミメティック大環状化合物
EP3466439A1 (en) * 2011-12-09 2019-04-10 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
AU2013221433B2 (en) 2012-02-15 2018-01-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
BR112014020103A2 (pt) 2012-02-15 2018-10-09 Aileron Therapeutics, Inc. macrociclos peptidomiméticos
CA2870200A1 (en) * 2012-04-12 2013-10-17 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
EP2879689A4 (en) 2012-08-02 2015-12-16 Stealth Peptides Int Inc METHOD FOR THE TREATMENT OF ATHEROSCLEROSIS
WO2014138429A2 (en) 2013-03-06 2014-09-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and use thereof in regulating hif1alpha
US9850278B2 (en) 2013-04-25 2017-12-26 Carmel-Haifa University Economic Corp. Synthetic anti-inflammatory peptides and use thereof
CA2942143A1 (en) * 2014-03-03 2015-09-11 Stealth Biotherapeutics Corp Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same
EP3502132A1 (en) * 2014-05-28 2019-06-26 Stealth BioTherapeutics Corp Therapeutic compositions including therapeutic small molecules and uses thereof
EP3501532A3 (en) 2014-05-28 2019-07-17 Stealth BioTherapeutics Corp Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
HUE054626T2 (hu) * 2014-06-25 2021-09-28 Flamma Spa Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
WO2016001042A1 (en) 2014-06-30 2016-01-07 Flamma S.P.A. Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
WO2016004093A2 (en) * 2014-07-01 2016-01-07 Stealth Biotherapeutics Corp Therapeutic compositions including galectin-3 inhibitors and uses thereof
SG11201702223UA (en) 2014-09-24 2017-04-27 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
US20160228491A1 (en) * 2015-02-09 2016-08-11 Stealth Biotherapeutics Corp Therapeutic compositions including phenazine-3-one and phenothiazine-3-one derivatives and uses thereof
CA2979847A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2016209261A1 (en) * 2015-06-26 2016-12-29 Stealth Biotherapeutics Corp Therapeutic compositions including gramicidin s peptidyl conjugates or imidazole-substituted fatty acids, variants thereof, and uses thereof
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1
EP4088744A1 (en) * 2015-10-21 2022-11-16 The Regents Of The University Of Michigan Detection and treatment of caries and microcavities with nanoparticles
WO2017093897A1 (en) * 2015-11-30 2017-06-08 Peter Schiller Aromatic-cationic peptides conjugated to antioxidants and their use in treating complex regional pain syndrome
EP3542822A4 (en) 2016-11-16 2020-08-19 Luca Science Inc. PROCESS FOR THE PRODUCTION OF MYOCARDIAL STEM CELL USED FOR THE TREATMENT AND / OR PREVENTION OF HEART ARREST
EP3563833A4 (en) * 2016-12-28 2020-07-01 Chugai Seiyaku Kabushiki Kaisha SELF-EMULSIFYING DRUG FORMULATION TO IMPROVE TRANSMEMBRANEOUS PASSAGE OF COMPOUNDS
CN107230021B (zh) * 2017-06-08 2020-05-26 桂林理工大学 筛选供水管网泄漏区域的方法
CN112672765A (zh) * 2018-06-29 2021-04-16 格莱科斯生物医药公司 结合物
WO2021132735A2 (en) 2019-12-27 2021-07-01 Luca Science Inc. Isolated mitochondria with smaller size and lipid membrane-based vesicles encapsulating isolated mitochondria
US20230212570A1 (en) * 2020-04-23 2023-07-06 North Carolina State University Cell-penetrating peptide-microrna conjugates for intracellular cell delivery
MX2023002772A (es) 2020-09-09 2024-04-05 Social Profit Network Métodos y composiciones para el suministro de biotina a las mitocondrias.

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967069D1 (en) * 1978-01-16 1984-08-02 Univ Boston Effecting cellular uptake of molecules
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
ATE136905T1 (de) 1988-06-30 1996-05-15 Astra Ab Dermorphin-analoge, deren herstellungsverfahren, pharmazeutische zusammensetzungen und methode zur therapeutischen behandlung unter verwendung der analoge
US5602100A (en) * 1988-06-30 1997-02-11 Astra Ab Dermorphin analogs having pharmacological activity
US5747641A (en) 1989-12-21 1998-05-05 Biogen Inc Tat-derived transport polypeptide conjugates
US5169934A (en) * 1990-05-14 1992-12-08 Anergen, Inc. Intracellularly cleavable compounds
NL9001639A (nl) 1990-07-19 1992-02-17 Amc Amsterdam Pt-houdende verbinding, werkwijze voor de bereiding ervan, alsmede toepassing van dergelijke verbindingen.
US5714327A (en) 1990-07-19 1998-02-03 Kreatech Diagnostics Platinum-containing compounds, methods for their preparation and applications thereof
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5674534A (en) 1992-06-11 1997-10-07 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
US5716644A (en) 1992-06-11 1998-02-10 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
IS4261A (is) 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
EP0747092B1 (en) 1995-06-09 2003-12-03 Hisamitsu Pharmaceutical Co., Inc. Matrix for iontophoresis
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
WO1999029721A1 (en) * 1997-12-10 1999-06-17 Washington University Anti-pathogen system and methods of use thereof
US6268398B1 (en) 1998-04-24 2001-07-31 Mitokor Compounds and methods for treating mitochondria-associated diseases
US7138103B2 (en) * 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US6703381B1 (en) * 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
SE9900961D0 (sv) 1999-03-16 1999-03-16 Astra Ab Novel compounds
US6669951B2 (en) * 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
DE60042338D1 (de) 1999-10-04 2009-07-16 Univ New Jersey Med TAR RNA bindende Peptide
US6759520B1 (en) 1999-10-28 2004-07-06 The New England Medical Center Hospitals, Inc. Chimeric analgesic peptides
US20050192215A1 (en) 2000-01-21 2005-09-01 Malabika Ghosh Methods and materials relating to novel polypeptides and polynucleotides
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
DE60143945D1 (de) * 2000-07-18 2011-03-10 Cornell Res Foundation Inc Medizinische verwendung von agonisten des mu-opioid rezeptors
US6900178B2 (en) 2000-09-12 2005-05-31 University Of Kentucky Research Foundation Protection against ischemia and reperfusion injury
GB0026924D0 (en) * 2000-11-03 2000-12-20 Univ Cambridge Tech Antibacterial agents
MXPA03007358A (es) * 2001-02-16 2004-12-13 Cellgate Inc Transportadores que contienen porciones de arginina separadas.
DE10121982B4 (de) * 2001-05-05 2008-01-24 Lts Lohmann Therapie-Systeme Ag Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung
US20070015146A1 (en) 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
DK2656854T3 (en) 2003-02-04 2015-07-06 Cornell Res Foundation Inc Applications of an aromatic-cationic peptide
DK1625149T3 (en) 2003-05-01 2016-05-30 Cornell Res Foundation Inc METHOD AND carrying complexes for delivery of molecules to cells
US7232824B2 (en) 2003-09-30 2007-06-19 Scios, Inc. Quinazoline derivatives as medicaments
CA2971928C (en) 2004-01-23 2019-01-08 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
US20050272101A1 (en) 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
CA2947343C (en) 2005-09-16 2019-04-30 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
US20070259377A1 (en) 2005-10-11 2007-11-08 Mickey Urdea Diabetes-associated markers and methods of use thereof
US20080027082A1 (en) 2006-06-19 2008-01-31 Berthold Hocher Use of adenosine a1 antagonists in radiocontrast media induced nephropathy
CN101939019B (zh) 2008-02-07 2014-07-16 康奈尔大学 用于预防或治疗胰岛素抵抗性的方法
EP2262520B1 (en) 2008-02-26 2017-05-03 Cornell University Compositions for prevention and treatment of renal injury
US11079645B2 (en) 2018-06-29 2021-08-03 Reald Spark, Llc Stabilization for privacy display

Similar Documents

Publication Publication Date Title
JP2011168603A5 (ja)
JP2012081521A5 (ja)
JP2013525942A5 (ja)
JP2011170856A5 (ja)
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
JP2011105738A5 (ja)
JP2013532130A5 (ja)
JP2015501646A5 (ja)
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
JP2013543797A5 (ja)
ITAN20120150A1 (it) Servomeccanismo per l'apertura di una serratura.
EA201370149A1 (ru) Антагонисты рецептора
FI20116212A (fi) Polypeptidi
JP2012044147A5 (ja)
JP2011170857A5 (ja)
JP2011181497A5 (ja)
EP2668951A4 (en) 1,2,4-OXADIAZOL DERIVATIVES AS MODULATOR RECEPTOR MEDICINES FOR GLP-1 PEPTIDE
DK2785675T5 (da) 5,5-dimethyl-2-propyl-hexahydro-2,4a-methanonaphthalen-1-on som duftmiddel
IT1404107B1 (it) Portamenu'.
ITMI20111829A1 (it) Procedimento per la preparazione di una composizione a base di equolo
CA2735430A1 (en) Straight-n-go
TH117776B (th) ชิ้นส่วนก่อสร้าง
TH120671B (th) ด้ามแปรงสีฟัน
TH122029B (th) ด้ามแปรงสีฟัน
TH117780B (th) ชิ้นส่วนก่อสร้าง